|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
|
|---|---|---|---|---|
| Assets: | ||||
| Current asset – cash | ||||
| Deferred offering costs | ||||
| Cash and cash equivalents | ||||
| Prepaid expenses current | ||||
| Total current assets | ||||
| Cash and marketable securities held in Trust Account | ||||
| Prepaid expenses non-current | ||||
| Total non-current assets | ||||
| Total Assets | ||||
| Accounts payable | ||||
| Accrued expenses | ||||
| Accrued offering costs | ||||
| Promissory note – related party | ||||
| Over-allotment option liability | ||||
| Total current liabilities | ||||
| Deferred underwriting commissions | ||||
| Total non-current liabilities | ||||
| Total Liabilities | ||||
| Class A ordinary shares subject to possible redemption, $0.0001 par value; 22,000,000 shares issued and outstanding at redemption value of $10.20 and $10.03 per share as of June 30, 2026 and December 31, 2025, respectively | ||||
| Common stock value | ||||
| Common Class A | ||||
| Common Class B | ||||
| Additional paid-in capital | ||||
| Accumulated deficit | ||||
| Total Shareholders’ Deficit | ||||
| Total Liabilities, Class A Ordinary Shares Subject to Redemption, and Shareholders’ Deficit |
Loading...
